Zobrazeno 1 - 10
of 150
pro vyhledávání: '"Hugues De Lavallade"'
Autor:
Jorge Cortes, Michael Deininger, Elza Lomaia, Beatriz Moiraghi, Soledad Undurraga, Carolina Pavlovsky, Charles Chuah, Tomasz Sacha, Jeffrey H. Lipton, James Mccloskey, Philippe Rousselot, Gianantonio Rosti, Hugues de Lavallade, Christine Rojas, Anna Turkina, Moshe Talpaz, Michael Mauro, Vickie Lu, Alexander Vorog, Jane Apperley
Publikováno v:
HemaSphere, Vol 7, p e85501cf (2023)
Externí odkaz:
https://doaj.org/article/f0b8d7a160ec4ce1b84d936813ace846
Autor:
Patrick Harrington, Katie J. Doores, Jamie Saunders, Marc de Lord, Chandan Saha, Thomas Lechmere, Hataf Khan, Ho Pui Jeff Lam, Amy O’ Reilly, Claire Woodley, Susan Asirvatham, Richard Dillon, Natalia Curto-Garcia, Jennifer O’ Sullivan, Shahram Kordasti, Kavita Raj, Michael H. Malim, Deepti Radia, Donal McLornan, Claire Harrison, Hugues de Lavallade
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 4, Pp 1-4 (2022)
Externí odkaz:
https://doaj.org/article/8d141df5a2af44408d61b05902336c10
Autor:
Patrick Harrington, Richard Dillon, Deepti Radia, Philippe Rousselot, Donal P. McLornan, Mark Ong, Anna Green, Alessandro Verde, Farzana Hussain, Kavita Raj, Shahram Kordasti, Claire Harrison, Hugues de Lavallade
Publikováno v:
Haematologica, Vol 108, Iss 6 (2023)
Dasatinib is a multi-kinase inhibitor with activity against the SRC kinase LCK, which plays a critical role in T-cell receptor signaling. Dasatinib, initially developed as an immunosuppressive agent, is by contrast, also noted to result in enhanced t
Externí odkaz:
https://doaj.org/article/4311aefbb9da4c69beada3dd4677919f
Autor:
Vipul Sheth, Victoria Potter, Hugues de Lavallade, Shreyans Gandhi, Austin Kulasekararaj, Pramila Krishnamurthy, Varun Mehra, Francesco Dazzi, Ghulam Mufti, Antonio Pagliuca, Donal Mclornan, Kavita Raj
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 7, Pp 1-6 (2021)
Abstract Pre-emptive DLI (pDLI) is an effective strategy in lowering the risk of relapse without significantly increasing the risk of graft-versus-host disease (GVHD) in the case of T cell lineage mixed chimerism (MC) post allogeneic transplant in he
Externí odkaz:
https://doaj.org/article/6a6208a955b94bbda77e11e80c805e95
Autor:
Jamie Saunders, Natalia Curto-Garcia, Priya Sriskandarajah, Jennifer O’Sullivan, Claire Woodley, Susan Asirvatham, Marion Campbell-Drew, Jonathan Mathias, Tim Ellis, Nona Baker, Deepti H. Radia, Sahra Ali, Shahram Kordasti, Patrick Harrington, Hugues de Lavallade, Donal P. McLornan, Claire N. Harrison
Publikováno v:
HemaSphere, Vol 5, Iss 7, p e609 (2021)
Externí odkaz:
https://doaj.org/article/35ea45023d78488a8677879e2168635a
Autor:
Alesia Khan, Claire Woodley, Deepti Radia, George N. Mikhaeel, Jessica Brady, Natalia Curto Garcia, Patrick Harrington, Jennifer O’Sullivan, Shahram Kordasti, Yvonne Francis, Susan Asirvatham, Sahra Ali, Priya Sriskandarajah, Jamie Saunders, Hugues de Lavallade, Donal P. McLornan, Claire N. Harrison
Publikováno v:
HemaSphere, Vol 5, Iss 7, p e611 (2021)
Externí odkaz:
https://doaj.org/article/9bf13ba33ca94e558c21db22cc1d45ba
Autor:
Vipul Sharad Sheth, Victoria Potter, Shreyans A. Gandhi, Austin Gladston Kulasekararaj, Hugues de Lavallade, Petra Muus, Antonio Pagliuca, Carmel F.M. Rice, Varun Mehra, Francesco Grimaldi, Shafqat Inam, Linda D. Barber, Ghulam J. Mufti, Judith C. Marsh
Publikováno v:
Blood Advances, Vol 3, Iss 20, Pp 3070-3079 (2019)
Abstract: Survival after allogeneic hematopoietic cell transplantation (HSCT) for severe aplastic anemia (SAA) among older patients remains poor and associated with increased risk for graft-versus-host disease (GVHD). In this retrospective study of 6
Externí odkaz:
https://doaj.org/article/0f89fc0d433c4eb898fa0e957c32e39a
Autor:
Bruno Fattizzo, Austin G. Kulasekararaj, Anita Hill, Nana Benson-Quarm, Morag Griffin, Talha Munir, Louise Arnold, Kathryn Riley, Robin Ireland, Hugues De Lavallade, Victoria Potter, Dario Consonni, Peter Hillmen, Ghulam J. Mufti, Wilma Barcellini, Judith C. W. Marsh
Publikováno v:
Haematologica, Vol 104, Iss 11 (2019)
Externí odkaz:
https://doaj.org/article/afbb1a7b67a04e4691e516000cf260fe
Publikováno v:
European Medical Journal Hematology, Vol 5, Iss 1, Pp 53-61 (2017)
This symposium was dedicated to discussing BCR-ABL-positive chronic myeloid leukaemia (CML) and Philadelphia-positive acute lymphoblastic leukaemia (Ph+ALL). Prof Baccarani opened the symposium, highlighting the recent improvements in survival in pat
Externí odkaz:
https://doaj.org/article/57dc87f5c13743e0bab6f7a80a4378b8
Autor:
Hugues de Lavallade, Aytug Kizilors
Publikováno v:
European Medical Journal Oncology, Vol 4, Iss 1, Pp 86-95 (2016)
Since their introduction in 2001, tyrosine kinase inhibitors (TKIs) targeting BCR-ABL have become the standard therapy for chronic myeloid leukaemia (CML). While allogeneic hematopoietic stem cell transplant is a recognised curative treatment for CML
Externí odkaz:
https://doaj.org/article/7f14c9d406f54e688bd967a1fd93adb8